Chemotherapy information sheets

Chemotherapy is a type of systemic anti-cancer therapy (SACT). Chemotherapy information sheets provide details about individual chemotherapy treatments. Your doctor will discuss your treatment with you when you come to The Christie.

Each information sheet includes:

  • name of drugs
  • the way the drugs are given, for example, injection or via a drip
  • treatment cycle (which days or weeks you have treatment and how long treatment lasts)
  • side effects and how to cope
  • contact numbers

Click on the name of the treatment you wish to view.

Or find it alphabetically:



Nivolumab is a treatment which helps to reactivate the immune system  so that you are able to fight the cancer.  Your treatment will be fully explained by your doctor or nurse, who will be happy to answer any questions. 

Nab-paclitaxel (Abraxane)

This leaflet is offered as a guide to you and your family.  You will find it useful to refer to the booklet Chemotherapy: a guide which gives general information on chemotherapy and side effects.

Nab-paclitaxel (Abraxane) and gemcitabine

This leaflet is offered as a guide to you and your family.  The possible benefits of treatment vary: for some people chemotherapy may reduce the risk of the cancer coming back, for others chemotherapy may control the cancer and its symptoms.  

Niraparib (Zejula®)

Niraparib is given by mouth as capsules once a day continuously. You can remain on the capsules for as long as you are benefitting from the treatment and the side effects are tolerated.

Capsules should be taken daily. Try to take them at the same times each day. If you forget to take a dose, do not double up, just take your next dose when it is due. Taking Niraparib at bedtime may help you to manage nausea. Swallow the capsules whole, with some water. Do not chew or crush the capsules.


Nilotinib is a targeted (biological) therapy. The possible benefits of treatment vary. This group of drugs block the growth and spread of cancer. They target and interfere with processes in the cells that cause cancer to grow.

Neratinib (Nerlynx®)

Neratinib is a targeted (biological) therapy. Neratinib belongs to a category of medications called tyrosine kinase inhibitors. This group of drugs block the growth and spread of cancer. They target and interfere with processes in the cells that cause cancer to grow. Neratinib works by irreversibly binding to and inhibiting specific receptors in cancer cells called HER2 and EGFR receptors. These receptors are responsible for
helping cancer cells grow and multiply. By inhibiting the HER2 and EGFR receptors with neratinib, cancer cells can no longer continue growing and multiplying.